The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

PALEXIA 20 mg/ml oral solution

Grunenthal Pharma LtdPA2242/012/011

Main Information

Trade NamePALEXIA 20 mg/ml oral solution
Active SubstancesTapentadol hydrochloride
Dosage FormOral solution
Licence HolderGrunenthal Pharma Ltd
Licence NumberPA2242/012/011

Group Information

ATC CodeN02AX Other opioids
N02AX06 tapentadol


License statusAuthorised
Licence Issued25/01/2013
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back